Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17267741rdf:typepubmed:Citationlld:pubmed
pubmed-article:17267741lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C0235989lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C0016016lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C1705165lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C2700061lld:lifeskim
pubmed-article:17267741lifeskim:mentionsumls-concept:C0722236lld:lifeskim
pubmed-article:17267741pubmed:issue3lld:pubmed
pubmed-article:17267741pubmed:dateCreated2007-2-28lld:pubmed
pubmed-article:17267741pubmed:abstractTextPlasminogen (Plg) activator inhibitor-1 (PAI-1) is an important fibrosis-promoting molecule. Whether this effect can be attributed to PAI-1's activity as an inhibitor of plasmin generation is debated. This study was designed to investigate the role of Plg in renal fibrosis using in vivo and in vitro approaches. Plg-deficient (Plg-/-) and wild-type (Plg+/+) C57BL/6 mice were subjected to unilateral ureteral obstruction or sham surgery (n = 8/group; sham, days 3, 7, 14, and 21). Plg deficiency was confirmed by the absence of Plg mRNA, protein, and plasmin activity. After 21 d of unilateral ureteral obstruction, total kidney collagen was significantly reduced by 35% in the Plg-/- mice. Epithelial-to-mesenchymal transition (EMT), as typified by tubular loss of E-cadherin and acquisition of alpha-smooth muscle actin, was also significantly reduced in Plg-/- mice, 76% and 50%, respectively. Attenuation of EMT and fibrosis severity in the Plg-/- mice was associated with significantly lower levels of phosphorylated extracellular signal-regulated kinase (ERK) and active TGF-beta. In vitro, addition of plasmin (20 microg/ml) to cultures of murine tubular epithelial cells initiated ERK phosphorylation within minutes, followed by phenotypic transition to fibroblast-specific protein-1+, alpha-smooth muscle actin+, fibronectin-producing fibroblast-like cells. Both plasmin-induced ERK activation and EMT were significantly blocked in vitro by the protease-activated receptor-1 (PAR-1) silencing RNA; by pepducin, a specific anti-PAR-1 signaling peptide; and by the ERK kinase inhibitor UO126. Plasmin-induced ERK phosphorylation was enhanced in PAR-1-overexpressing tubular cells. These findings support important profibrotic roles for plasmin that include PAR-1-dependent ERK signaling and EMT induction.lld:pubmed
pubmed-article:17267741pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:languageenglld:pubmed
pubmed-article:17267741pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:citationSubsetIMlld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17267741pubmed:statusMEDLINElld:pubmed
pubmed-article:17267741pubmed:monthMarlld:pubmed
pubmed-article:17267741pubmed:issn1046-6673lld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:EddyAllison...lld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:DegenJay LJLlld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:ZhangGuoqiang...lld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:CaiXiaoheXlld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:López-GuisaJe...lld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:CollinsSarah...lld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:KernanKelly...lld:pubmed
pubmed-article:17267741pubmed:authorpubmed-author:ShvilYigalYlld:pubmed
pubmed-article:17267741pubmed:issnTypePrintlld:pubmed
pubmed-article:17267741pubmed:volume18lld:pubmed
pubmed-article:17267741pubmed:ownerNLMlld:pubmed
pubmed-article:17267741pubmed:authorsCompleteYlld:pubmed
pubmed-article:17267741pubmed:pagination846-59lld:pubmed
pubmed-article:17267741pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:meshHeadingpubmed-meshheading:17267741...lld:pubmed
pubmed-article:17267741pubmed:year2007lld:pubmed
pubmed-article:17267741pubmed:articleTitlePlasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.lld:pubmed
pubmed-article:17267741pubmed:affiliationChildren's Hospital & Regional Medical Center, 4800 Sand Point Way NE, Division of Nephrology, Mail Stop M1-5, Seattle, WA 98105, USA.lld:pubmed
pubmed-article:17267741pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17267741pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17267741pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:18815entrezgene:pubmedpubmed-article:17267741lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17267741lld:pubmed